Abstract
The selective competitive bradykinin (Bk) antagonist, B4148 (Lys-Lys-[Hyp2, Thi5,8, DPhe7]-Bk) infused at 100 micrograms kg-1 min-1 into rats produced a significant inhibition of the hypotensive effect of Bk and had no effect against acetylcholine-induced responses. In a rat model of endotoxin shock, the fall in mean arterial blood pressure in response to an intravenous injection of lipopolysaccharide from E. coli was significantly attenuated by the same infusion of B4148 compared to controls. These findings suggest that kinins are involved in the hypotensive response to endotoxin shock in rats. The development of potent Bk antagonists offers a new experimental approach for evaluating the role of kinins in this and other disease states and potential therapy in such disorders.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aasen A. O., Smith-Erichsen N., Amundsen E. Plasma kallikrein-kinin system in septicemia. Arch Surg. 1983 Mar;118(3):343–346. doi: 10.1001/archsurg.1983.01390030075012. [DOI] [PubMed] [Google Scholar]
- Högström H., Claeson G., Larsson-Backström C., Lundberg D., Wenngren E., Haglund U. Septic shock in the rat: activation of plasma proteolytic systems and effects of a kallikrein inhibitor/bradykinin antagonist (S-2441). Acta Chir Scand. 1987 Mar;153(3):161–164. [PubMed] [Google Scholar]
- Kalter E. S., van Dijk W. C., Timmerman A., Verhoef J., Bouma B. N. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. J Infect Dis. 1983 Oct;148(4):682–691. doi: 10.1093/infdis/148.4.682. [DOI] [PubMed] [Google Scholar]
- Kühne H., Schaper U., Lehmann B., Dassler S., Scheuch D. W. Zur Aktivierung des Kallikrein-Kinin-Systems durch Endotoxin im experimentellen Schockmodell der Ratte. Z Med Lab Diagn. 1985;26(2):67–70. [PubMed] [Google Scholar]
- Levine B. W., Talamo R. C., Kazemi H. Action and metabolism of bradykinin in dog lung. J Appl Physiol. 1973 Jun;34(6):821–826. doi: 10.1152/jappl.1973.34.6.821. [DOI] [PubMed] [Google Scholar]
- McConn R., Wasserman F., Haberland G. The kallikrein-kinin system in the acutely-ill: (A) changes in plasma kininogen in acutely-ill patients. (B) the efficacy of pulmonary clearance of bradykinin. Adv Exp Med Biol. 1983;156(Pt B):1019–1035. [PubMed] [Google Scholar]
- Vavrek R. J., Stewart J. M. Competitive antagonists of bradykinin. Peptides. 1985 Mar-Apr;6(2):161–164. doi: 10.1016/0196-9781(85)90033-6. [DOI] [PubMed] [Google Scholar]
- Whalley E. T., Nwator I. A., Stewart J. M., Vavrek R. J. Analysis of the receptors mediating vascular actions of bradykinin. Naunyn Schmiedebergs Arch Pharmacol. 1987 Oct;336(4):430–433. doi: 10.1007/BF00164878. [DOI] [PubMed] [Google Scholar]